| Anti‐PD‐1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases P Dhupkar, N Gordon, J Stewart, ES Kleinerman Cancer Medicine 7 (6), 2654-2664, 2018 | 146 | 2018 |
| Interleukin-2: old and new approaches to enhance immune-therapeutic efficacy P Dhupkar, N Gordon Immunotherapy, 33-51, 2017 | 75 | 2017 |
| Effects of anti-EGFR antibody cetuximab on androgen-independent prostate cancer cells P Dhupkar, M Dowling, K Cengel, B Chen Anticancer research 30 (6), 1905-1910, 2010 | 26 | 2010 |
| A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies X Fan, RJ Brezski, H Deng, PM Dhupkar, Y Shi, A Gonzalez, S Zhang, ... Molecular cancer therapeutics 14 (3), 681-691, 2015 | 21 | 2015 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells P Dhupkar, H Zhao, K Mujoo, Z An, N Zhang Biochemistry and biophysics reports 8, 382-388, 2016 | 10 | 2016 |
| Ethical dimensions in randomized trials and off-label use of investigational drugs for COVID-19 treatment P Dhupkar, S Mukherjee Clinical Ethics 17 (1), 95-104, 2022 | 2 | 2022 |
| Combination of Interleukin-11R [alpha] chimeric antigen receptor T-cells and programmed death-1 blockade as an approach to targeting osteosarcoma cells In vitro H Moonat, G Huang, P Dhupkar, K Schadler, N Gordon, E Kleinerman Cancer Translational Medicine 3 (4), 2017 | 1 | 2017 |
| Targeting PD-1/PDL-1 Signaling in the Treatment of Osteosarcoma Lung Metastasis P Dhupkar | 1 | 2016 |
| Combination of Interleukin-11Ra chimeric antigen receptor T-cells and programmed death-1 blockade as an approach to targeting osteosarcoma cells In vitro H Moonat, G Huang, P Dhupkar, K Schadler, N Gordon, E Kleinerman Cancer Translational Medicine 3 (4), 139-139, 2017 | | 2017 |
| Immune modulation through targeting PD-1/PDL-1 signaling pathway for the treatment of osteosarcoma lung metastastasis PM Dhupkar, L Yu, N Gordon, ES Kleinerman Journal for ImmunoTherapy of Cancer 3, 1-1, 2015 | | 2015 |
| Immune modulation of natural killer cell adoptive transfer for the treatment of Osteosarcoma lung metastastasis: Targeting the PD-1/PDL-1 signaling pathway PM Dhupkar, E Kleinerman, N Gordon CANCER IMMUNOLOGY RESEARCH 3 (10), 2015 | | 2015 |
| Abstract A65: Immune modulation of natural killer cell adoptive transfer for the treatment of Osteosarcoma lung metastastasis: Targeting the PD-1/PDL-1 signaling pathway PM Dhupkar, E Kleinerman, N Gordon Cancer Immunology Research 3 (10_Supplement), A65-A65, 2015 | | 2015 |
| Abstract P5-11-03: Deciphering the role of HER3-DJ-1 interaction in breast cancer S Mukherjee, Z Huang, M Fa, P Dhupkar, K Mujoo, N Zhang, Z An Cancer Research 73 (24_Supplement), P5-11-03-P5-11-03, 2013 | | 2013 |
| Abstract P5-11-09: Crk II adaptor proteins as positive regulators of HER3 signaling in breast cancer P Dhupkar, H Zhao, S Mukherjee, K Mujoo, N Zhang, Z An Cancer Research 73 (24_Supplement), P5-11-09-P5-11-09, 2013 | | 2013 |
| Effects of epidermal growth factor receptor antibody Cetuximab (C225) in prostate cancer cells PM Dhupkar University of the Sciences in Philadelphia, 2008 | | 2008 |
